Remove Clinical Supply Remove Drugs Remove Long-Term Care Facilities Remove Virus
article thumbnail

Keeping tabs on Covid-19: BioNTech buys GMP-certified facility to boost vaccine…

The Pharma Data

The Marburg facility is expected to start the production of mRNA formulation for a Covid-19 vaccine in the first half of 2021, pending regulatory authorization or approval.

Vaccine 52